World First - Celiac Disease Vaccine Trialled in Australia on April 2009 - Exciting News!

If you are a celiac, your miracle cure is underthat remain after its digestion in the gut. These
way - being trialled in Melbourne Australia beginninggluten fragments can be synthesized using fairly
April 2009! It could conceivably desensitize peoplestandard chemistry and are the basis for the
with CD to the point that the villi in their smallceliac vaccine."
intestine are not damaged by the gluten protein.The Celiac Vaccine Trials
However with the need for extensive testing inThe original research began at Oxford England in
this three phase trial, the vaccine may not be1997. The work continued in Australia in 2002 and
ready for release for several years.by April 2009 Bob Anderson from the Walter and
Before we go into the details of such a cure itEliza Hall Institute of Medical research (Melbourne,
should be noted that this vaccine might not be aAustralia) will commence the first world trials of a
'magic bullet' that makes people permanentlyceliac vaccine that could reduce or eradicate the
immune to the gluten protein, it might 'only'need for being gluten free. In fact Bob Anderson
desensitize them. Also be aware that if youcalls the vaccine a "next-generation desensitization
choose to undertake the 'therapy' there are notherapy" that has been successful in mice and is
guarantees of how you will react, and the onlysoon to be tested on celiacs.
way to regularly check to see if you have been"The vaccine will be tested on 40 volunteers with
'cured' would be regular intestine biopsies. As it isCD over 11 months to establish that it does not
known that some people take over two years toharm them. In a subsequent phase 2 trial, which is
heal their intestines from gluten damage, howdesigned to find out if the treatment is effective,
risky will this strategy be? It is expected thatvolunteers will receive the treatment and then be
testing will be extensive so these questions maychallenged with foods containing gluten. Their
all sit under the 'devil's advocate' category, and allimmune response and intestines will then be
may be well.examined to see if a tolerance to gluten has
An even more philosophical question is whatdeveloped. The therapy involves repeatedly
effect covering up the cause of your disease willinjecting solutions of gluten at increasing
have on your body. Books have been writtenconcentrations. The aim is to desensitize the
that suggest that it is the increased glutensubjects slowly, in a similar way to hay fever and
potency in wheat and other gluten grains as welldust allergy desensitization treatments."
as increased use in manufactured foods that hasTesting process
led to an overdose of gluten. Our bodies then"For a new drug to be accepted for use in people
pass a 'tipping point' where our geneticin Australia, Europe, or North America it must
predisposition to CD turns into an active disease.have progressed successfully from Phase 1
If this is true, how wise would it be to continue(safety) studies usually involving up to about 30
ingesting unnaturally high levels of gluten, oncevolunteers, to Phase 2 (efficacy) studies to show
'cured' just because we can? Sure it would makethat "it works" in people with the medical condition
life simpler not following a gluten free diet,of interest (typically about 200 volunteers in
however maybe we should wait for gluten to beseveral locations around the world), and to Phase
decreased at the source, the growing fields,3 (similar to Phase 2 but involving several
before we return to a gluten filled diet.thousand volunteers in many sites around the
Different types of CD identifiedworld)."
With all these issues under consideration, I amThe celiac vaccine future
sure that every celiac would still be interested in aDue to difficulties in funding, Bob Anderson
'cure'. A July 2007 article based on research(Walter and Eliza Hall Institute) co-founded a
conducted in Victoria, Australia, showed thatcommercial company called Nexpep to develop
"Celiac disease - is strongly associated with humanthe vaccine. Nucleus Network, Centre for Clinical
leukocyte antigen (HLA) DQ2 and to a lesserStudies (CCS) in the Alfred Hospital in Melbourne,
extent with HLA DQ8."will be conducting the Phase 1 clinical trial.
"HLA genes are part of the majorThe difficulty he has faced, besides the technical
histocompatibility complex (MHC), which plays aissues, is the low diagnosis level of CD and the
pivotal role in the immune system. HLA-DQ2mass of associated symptoms has made a
mediated CD is common in people of Europeanvaccine cure unattractive to traditional
ancestry, with about 90 per cent of suffererspharmaceutical companies. These companies
positive for DQ2. Another five per cent possessalways prefer well defined markets to accurately
HLA DQ8. In China and East Asia, DQ2 genes areforecast payback periods for their R&D and
rare while DQ8 genes are as common as inmarketing expenses.
Europe."The facts are that for this vaccine to prove
So it appears that this preliminary research hasfinancially viable, The US will need to approve the
been able to isolate two main versions of CD.drug and doctors and celiacs will need to accept
However the molecular workings of the immunethe treatment. One report estimates that only
response in the two antigens appear to be very600,000 people are diagnosed with CD (out of the
different. The researchers discovered that T-cells5 million with CD in North America and Europe).
in people with DQ8-associated CD reacted quiteCompounded to the funding challenges is that
differently to the small proteins in gluten than thepreviously, globally, there have only been three
T-cells in people with the DQ2 form of the"randomized, controlled" studies of the gluten free
disease.diet - one in children and two in adults - the
"At the moment a gluten-free diet is the onlylargest with 57 participants."
treatment for celiac disease but nearly half theThe assessment of the vaccine treatment will
people on the diet still have damage to their smallrequire repeated endoscopy and collection of small
intestine. Consequently other therapies, including aintestine biopsies which are expensive and
vaccine and three different drugs, are in variousun-enjoyable for volunteers. However a recent
stages of development. The research teamtrial in Italy has shown that biopsies are still the
believes CD might be the first example of anonly 'almost' guaranteed method of assessing
immune disease where treatments aregluten damage. The study findings showed that
customized according to the genetic make-up of"two years after adopting a gluten free diet,
the patient."about half those people diagnosed with celiac
The celiac vaccine discoverydisease continued to have villous atrophy as
The discovery that lead to the creation of thesevere as when they were first diagnosed. Only
vaccine was that the one critical part of wheatabout one in five of those with severe intestinal
gluten protein that was toxic was the commondamage (villous atrophy) on a gluten free diet had
genetic version (HLA DQ2) of CD. "As much asraised (abnormal) blood levels of transglutaminase
the identity of the toxic component of gluten wasantibody, meaning that standard blood tests to
important, it was the way in which it was foundmonitor disease activity were relatively
that has proven to be even more important. Byineffective."
eating gluten in wheat, rye, or barley for threeSo while the development of this vaccine is an
days (even a single meal will suffice in someimportant step in potentially eradicating celiac
people), immune cells (T cells) that damage thedisease, philosophical questions still remain as
small intestine are mobilized into blood for a fewissues for the long term efficacy of the vaccines.
short days. The T cells in blood can be monitoredAs an Australian first, this research is applauded
and analyzed to define what part of gluten theyby the gluten free community. We wish the
recognize. The parts of gluten recognized by theresearchers and medical staff all of the best in
vast majority of T cells involved in CD can bedemystifying this illusive disease.
condensed to a few "short" fragments of gluten